Luis Buzón-Martín

16PUBLICATIONS
35CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander medicine and treatmentsEnvironmental epidemiologyRisk policyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

|Apr 09, 2026
Mortality risk of ESBL producers in Escherichia coli bacteraemia: a comprehensive analysis using the PROBAC cohort.

Paula Olivares-Navarro, María Teresa Pérez-Rodríguez, Adrián Sousa

|Apr 08, 2026
Resistance Framing, Temporal Risk Assumptions, and Public Health Priorities in the Long-Acting Antirretroviral Era.

Luis Buzón-Martín, María Luisa Montes, Jara Llenas-García

|Jan 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort.

Jesús Troya, Rafael Mican, María José Galindo

|Oct 23, 2025
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Luis Buzón-Martín, Maria Luisa Montes, Roberto Pedrero

Pageof 3

Frequent Collaborators

12 joint publications

Jesús Troya García

6 joint publications

Carmen Hidalgo-Tenorio

5 joint publications

Alfonso Cabello-Úbeda

4 joint publications

Jara Llenas-García